Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism: Symposium

Journal of Internal Medicine

Volumn 267, Issue 5, 2010, Pages 515-525

  Fais, S ^a  

^a Istituo Superiore di Sanità ^*  (Italy)

Author keywords

Cancer; Cancer chemotherapy; Detoxification enzymes; Drug resistance; Reactive oxygen species; Therapeutics

Indexed keywords

CASPASE; CISPLATIN; DOXORUBICIN; FLUOROURACIL; PROTON PUMP; PROTON PUMP INHIBITOR; REACTIVE OXYGEN METABOLITE; VINBLASTINE;

ACIDIFICATION; ACIDITY; ADENOCARCINOMA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CELL DEATH; CELL PROLIFERATION; CHEMOSENSITIZATION; CLINICAL TRIAL; CONFERENCE PAPER; DETOXIFICATION; DRUG TARGETING; ENZYME ACTIVATION; HUMAN; INHIBITION KINETICS; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; METASTASIS POTENTIAL; OSTEOSARCOMA; PEPTIC ULCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTON TRANSPORT; TUMOR CELL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; EXTRACELLULAR SPACE; HUMANS; HYDROGEN-ION CONCENTRATION; INTRACELLULAR SPACE; NEOPLASM METASTASIS; NEOPLASMS; PROTON PUMP INHIBITORS; PROTON PUMPS;

EID: 77950501364     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2010.02225.x     Document Type: Conference Paper

References (84)

1. Welch DR. Biologic considerations for drug targeting in cancer patients. Cancer Treat Rev 1987 14 : 351 358.
2. Gatenby RA. A change of strategy in the war on cancer. Nature 2009 459 : 508 509.
3. Trédan O, Galmarini CM, Patel K, Tannock IF. Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst 2007 99 : 1441 1454.
4. De Milito A, Fais S. Tumor acidity, chemoresistance and proton pump inhibitors. Future Oncol 2005 1 : 779 786. (Pubitemid 40959470)
5. Izumi H, Torigoe T, Ishiguchi H et al. Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. Cancer Treat Rev 2003 29 : 541 549. (Pubitemid 37428326)
6. Sennoune SR, Bakunts K, Marti′nez GM et al. Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. Am J Physiol Cell Physiol 2004 286 : 1443 1452. (Pubitemid 38649995)
7. Martinez-Zaguilan R, Lynch RM, Martinez GM, Gillies RJ. Vacuolar-type Hα-ATPases are functionally expressed in plasma membranes of human tumor cells. Am J Physiol Cell Physiol 1993 265 : C1015 29. (Pubitemid 2006273)
8. Lee AH, Tannock IF. Heterogeneity of intracellular pH and of mechanisms that regulate intracellular pH in populations of cultured cells. Cancer Res 1998 58 : 1901 1908. (Pubitemid 28217465)
9. Martinez-Zaguilan R, Seftor EA, Seftor RE, Chu YW, Gillies RJ, Hendrix MJ. Acidic pH enhances the invasive behaviour of human melanoma cells. Clin Exp Metastasis 1996 14 : 176 186. (Pubitemid 26074280)
10. Rofstad EK, Mathiesen B, Kindem K, Galappathi K. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res 2006 66 : 6699 6707. (Pubitemid 44085627)
11. Wachsberger PR, Landry J, Storck C. Mammalian cells adapted to growth at pH 6.7 have eleveted HSP27 levels and are resistant to cisplatin. Int J Hyperthermia 1997 13 : 251 255. (Pubitemid 27296605)
12. Raghunand N, Mahobey B, van Sluis R, Baggett B, Gillies RJ. Acute metabolic alkalosis enhances response of C3H mouse mammary tumors to the weak base mitoxantrone. Neoplasia 2001 3 : 227 235. (Pubitemid 32747571)
13. Glunde K, Guggino SE, Solaiyappan M, Pathak AP, Ichikawaz Y, Bhujwalla ZM. Extracellular acidification alters lysosomal trafficking in human breast cancer cells. Neoplasia 2003 5 : 533 545. (Pubitemid 38045090)
14. Martinez-Zaguilàn R, Raghunand N, Lynch RM et al. pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug resistant human breast carcinoma cell lines. Biochem Pharmacol 1999 57 : 1037 1046. (Pubitemid 29168552)
15. Lugini L, Lozupone F, Matarrese P et al. Potent phagocytic activity discriminates metastatic and primary human malignant melanomas: a key role of ezrin. Lab Invest 2003 83 : 1555 1567. (Pubitemid 37424017)
16. Lugini L, Matarrese P, Tinari A et al. Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells. Cancer Res 2006 66 : 3629 3638.
17. Fais S. Cannibalism: a way to feed on metastatic tumors. Cancer Lett 2007 258 : 155 164. (Pubitemid 350101021)
18. Huynh KK, Grinstein S. Regulation of vacuolar pH and its modulation by some microbial species. Microbiol Mol Biol Rev 2007 71 : 452 462. (Pubitemid 47429280)
19. Ferguson SJ, Ingledew WJ. Energetic problems faced by micro-organisms growing or surviving on parsimonious energy sources and at acidic pH: I. Acidithiobacillus ferrooxidans as a paradigm. Biochim Biophys Acta 2008 1777 : 1471 1479.
20. Martínez-Muñoz GA, Kane P. Vacuolar and plasma membrane proton pumps collaborate to achieve cytosolic pH homeostasis in yeast. J Biol Chem 2008 283 : 20309 20319.
21. Robertson N, Potter C, Harris AL. Role of carbonic anhydrase IX in human tumor cell growth, survival, invasion. Cancer Res 2004 64 : 6160 6165. (Pubitemid 39129417)
22. Nielsen D, Skovsgaard T. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines. Biochim Biophys Acta 1992 1139 : 169 183.
23. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993 62 : 385 427. (Pubitemid 23237876)
24. Dalton WS. Is P-glyccoprotein a potential target for reversing clinical drug resistance? Curr Opin Oncol 1994 6 : 595 600.
25. Raghunand N, He X, van Sluis R et al. Enhancement of chemotherapy by manipulation of tumor pH. Br J Cancer 1999 80 : 1005 1011.
26. Cole SPC, Bhardwaj G, Gerlach JH et al. Overexpression of a transporter gene in a multidrug-resistance human lung cancer cell line. Science 1992 95 : 1650 1658. (Pubitemid 23012438)
27. Scheper RJ, Broxterman HJ, Sceffer GL et al. Overexpression of a M 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 1993 53 : 1475 1479.
28. Izquierdo MA, Scheffer GL, Flens MJ, Schroeijers AB, van der Valk P, Scheper RJ. Major vault LRP-related multidrug resistance. Eur J Cancer 1996 32A : 979 984. (Pubitemid 126380282)
29. Doyle LA, Yang W, Abruzzo LV et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 1998 95 : 15665 15670. (Pubitemid 29018757)
30. Leonard GD, Fojo T, Bates SE. The role of ABC transporters in clinical practice. Oncologist 2003 8 : 411 424. (Pubitemid 37238869)
31. Simon S, Roy D, Schindler M. Intracellular pH and the control of multi-drug resistance. Proc Natl Acad Sci USA 1994 91 : 1128 1132.
32. Mahoney BP, Raghunand N, Baggett B, Gillies RJ. Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro. Biochem Pharmacol 2003 66 : 1207 1218. (Pubitemid 37130296)
33. Raghunand N, Gillies RJ. pH and drug resistance in tumors. Drug Resist Updat 2000 3 : 39 47. (Pubitemid 30246567)
34. Altan N, Chen Y, Schindler M, Simon SM. Defective acidification in human breast tumor cells and implications for chemotherapy. J Exp Med 1998 187 : 1583 1598. (Pubitemid 28235100)
35. Parolini I, Federici C, Raggi C et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem 2009 284 : 34211 34222.
36. Ouar Z, Bens M, Vignes C et al. Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells. Biochem J 2003 370 : 185 193. (Pubitemid 36259431)
37. Luciani F, Spada M, De Milito A et al. Effect of proton pump inhibitor pre-treatment on resistance of solid tumors to cytotoxic drugs. J Natl Cancer Inst 2004 96 : 1702 1713. (Pubitemid 39585639)
38. Mullin JM, Gabello M, Murray LJ et al. Proton pump inhibitors: actions and reactions. Drug Discov Today 2009 14 : 647 660.
39. Fais S, De Milito A, You H, Qin W. Targeting vacuolar H+-ATPases as a new strategy against cancers. Cancer Res 2007 67 : 10627 10630. (Pubitemid 350145883)
40. Hinton A, Bond S, Forgac M. V-ATPase functions in normal and disease processes. Pflugers Arch 2009 457 : 589 598.
41. You H, Jin J, Shu H et al. Small interfering RNA targeting the subunit ATP6L of proton pump V-ATPase overcomes chemoresistance of breast cancer cells. Cancer Lett 2009 280 : 110 119.
42. Sennoune SR, Luo D, Martinez-Zaguilan R. Plasmalemmal vacuolar-type H+-ATPase in cancer biology. Cell Biochem Biophys 2004 40 : 185 206. (Pubitemid 41270787)
43. +)-ATPases - nature's most versatile proton pumps. Nat Rev Mol Cell Biol 2002 3 : 94 103. (Pubitemid 37237147)
44. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006 12 : 895 904. (Pubitemid 44175140)
45. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006 127 : 679 695. (Pubitemid 44781029)
46. Lu X, Qin W, Li J et al. The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump. Cancer Res 2005 65 : 6843 6849. (Pubitemid 41060723)
47. Murakami T, Shibuya I, Ise T et al. Elevated expression of vacuolar proton pump genes and cellular pH in cisplatin resistance. Int J Cancer 2001 93 : 869 874. (Pubitemid 32756757)
48. Torigoe T, Izumi H, Ishiguchi H et al. Enhanced expression of the human vacuolar H+-ATPase c subunit gene (ATP6L) in response to anticancer agents. J Biol Chem 2002 277 : 36534 36543.
49. Der G. An overview of proton pump inhibitors. Gastroenterol Nurs 2003 26 : 182 190.
50. Metz DC, Forsmark C, Lew EA et al. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Am J Gastroenterol 2001 96 : 3274 3280. (Pubitemid 34016648)
51. Ramdani A, Mignon M, Samoyeau R. Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome. Gastroenterol Clin Biol 2002 26 : 355 359. (Pubitemid 34555809)
52. Chen M, Zou X, Luo H et al. Effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (SGC7901) cells. Cell Biol Int 2009 33 : 1008 1019.
53. Kasamon YL, Swinnen LJ. Treatment advances in adult Burkitt lymphoma and leukemia. Curr Opin Oncol 2004 16 : 429 435. (Pubitemid 39159169)
54. Nilsson A, De Milito A, Engstrom P et al. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics 2002 109 : e91.
55. De Milito A, Iessi E, Logozzi M et al. Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species. Cancer Res 2007 67 : 5408 5417. (Pubitemid 46997281)
56. Pérez-Sayáns M, García-García A, Reboiras-López MD, Gándara-Vila P. Role of V-ATPases in solid tumors: importance of the subunit C. Int J Oncol 2009 34 : 1513 1520.
57. Pérez-Sayáns M, Somoza-Martín JM, Barros-Angueira F, Rey JM, García-García A. V-ATPase inhibitors and implication in cancer treatment. Cancer Treat Rev 2009 35 : 707 713.
58. De Milito A, Canese R, Marino ML et al. pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity. Int J Cancer 2009 Oct 28.
59. Cardone RA, Casavola V, Reshkin SJ. The role of disturbed pH dynamics and the Na+/H exchanger in metastasis. Nat Rev Cancer 2005 5 : 786 795.
60. Harguindey S, Arranz JL, Wahl ML, Orive G, Reshkin SJ. Proton transport inhibitors as potentially selective anticancer drugs. Anticancer Res 2009 29 : 2127 2136.
61. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002 295 : 2387 2392. (Pubitemid 34270240)
62. Johnson LL, Pavlovsky AG, Johnson AR et al. A rationalization of the acidic pH dependence for stromelysin-1 (matrix metalloproteinase-3) catalysis and inhibition. J Biol Chem 2000 275 : 11026 11033.
63. Drochioiu G. Chronic metabolic acidosis may be the cause of cachexia: body fluid pH correction may be an effective therapy. Med Hypotheses 2008 70 : 1167 1173. (Pubitemid 351614954)
64. Kusuzaki K, Murata H, Matsubara T, et al. Acridine orange could be an innovative anticancer agent under photon energy. In Vivo 2007 21 : 205 221. (Pubitemid 46534272)
65. Andreev OA, Dupuy AD, Segala M, et al. Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo. Proc Natl Acad Sci USA 2007 104 : 7893 7898. (Pubitemid 47185847)
66. Robey IF, Baggett BK, Kirkpatrick ND et al. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res 2009 69 : 2260 2268.
67. Silva AS, Yunes JA, Gillies RJ, Gatenby RA. The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion. Cancer Res 2009 69 : 2677 2684.
68. Lee ES, Gao Z, Bae YH. Recent progress in tumor pH targeting nanotechnology. J Control Release 2008 132 : 164 170.
69. Makovitzki A, Fink A, Shai Y. Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides. Cancer Res 2009 69 : 3458 3463.
70. Sjøstrøm JE, Kühler T, Larsson H. Basis for the selective antibacterial activity in vitro of proton pump inhibitors against Helicobacter spp. Antimicrob Agents Chemother 1997 41 : 1797 1801. (Pubitemid 27339890)
71. Kochar DK, Saini G, Kochar SK et al. A double blind, randomised placebo controlled trial of rifampicin with omeprazole in the treatment of human cutaneous leishmaniasis. J Vector Borne Dis 2006 43 : 161 167. (Pubitemid 44901458)
72. Puiac S, Negrea A, Richter-Dahlfors A, Plant L, Rhen M. Omeprazole antagonizes virulence and inflammation in Salmonella enterica-infected RAW264.7 cells. Antimicrob Agents Chemother 2009 53 : 2402 2409.
73. Marchesini N, Vieira M, Luo S, Moreno SN, Docampo R. A malaria parasite-encoded vacuolar H(+)-ATPase is targeted to the host erythrocyte. J Biol Chem 2005 280 : 36841 36847. (Pubitemid 41587765)
74. Lozupone F, Perdicchio M, Brambilla D et al. The human homologue of Dictyostelium discoideum phg1A is expressed by human metastatic melanoma cells. EMBO Rep 2009 10 : 1348 1354.
75. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004 4 : 891 899.
76. Marquardt D, Center MS. Involvement of vacuolar H(+)-adenosine triphosphatase activity in multidrug resistance in HL60 cells. J Natl Cancer Inst 1991 83 : 1098 1102.
77. Semenza GL. Tumor metabolism: cancer cells give and take lactate. J Clin Invest 2008 118 : 3835 3837.
78. +-adenosine triphosphatase by N-methyl-N'-nitro-N-nitrosoguanidine in the gastric epithelial RGM-1 cell line. In Vitro Cell Dev Biol Anim. 2008 44 : 26 30.
79. Gervasoni JE Jr., Fields SZ, Krishna S, et al. Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Cancer Res 1991 51 : 4955 4963.
80. Klohs WD, Steinkampf RW. The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in multiple drug-resistant cells. Mol Pharmacol 1988 34 : 180 185.
81. Wahl ML, Owen JA, Burd R, et al. Regulation of intracellular pH in human melanoma: potential therapeutic implications. Mol Cancer Ther 2002 1 : 617 628.
82. Yeo M, Kim DK, Park HJ, Cho SW, Cheong JY, Lee KJ. Blockage of intracellular proton extrusion with proton extrusions with proton pump inhibitor induces apoptosis in gastric cancer. Cancer Sci 2008 99 : 185. (Pubitemid 350239049)
83. Morimura T, Fujita K, Akita M, Nagashima M, Satomi A. The proton pump inhibitor inhibits cell growth and induces apoptosis in human hepatoblastoma. Pediatr Surg Int 2008 24 : 1087 1094.
84. Di Sario A, Bendia E, Omenetti A, et al. Selective inhibition of ion transport mechanisms regulating intracellular pH reduces proliferation and induces apoptosis in cholangio carcinoma cells. Dig Liver Dis 2007 39 : 60 9. (Pubitemid 46024544)